Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Revenue

Virax Biolabs Group had revenue of $1.61K in the half year ending September 30, 2025, a decrease of -97.90%. This brings the company's revenue in the last twelve months to $2.99K, down -96.48% year-over-year. In the fiscal year ending March 31, 2025, Virax Biolabs Group had annual revenue of $6.33K, down -95.95%.

• Revenue (ttm): $2.99K
• Revenue Growth: -96.48%
• P/S Ratio: 2,061.73
• Revenue / Employee: $157
• Employees: 19
• Market Cap: 6.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.33K	-150.09K	-95.95%
Mar 31, 2024	156.42K	147.86K	1,727.11%
Mar 31, 2023	8.56K	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	123.82K	23.94K	23.97%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 16, 2026

Data Sources Report a data error